241 related articles for article (PubMed ID: 3643771)
1. Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.
Foster JK; Lentino JR; Strodtman R; DiVincenzo C
Antimicrob Agents Chemother; 1986 Dec; 30(6):823-7. PubMed ID: 3643771
[TBL] [Abstract][Full Text] [Related]
2. In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus.
Smith SM
Antimicrob Agents Chemother; 1986 Feb; 29(2):325-6. PubMed ID: 2940966
[TBL] [Abstract][Full Text] [Related]
3. Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.
Chandrasekar PH; Sluchak JA
Chemotherapy; 1989; 35(5):333-7. PubMed ID: 2551600
[TBL] [Abstract][Full Text] [Related]
4. Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.
Maple PA; Hamilton-Miller JM; Brumfitt W
Antimicrob Agents Chemother; 1991 Feb; 35(2):345-50. PubMed ID: 1827242
[TBL] [Abstract][Full Text] [Related]
5. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Sep; 38(9):2065-72. PubMed ID: 7811020
[TBL] [Abstract][Full Text] [Related]
6. Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Stratton CW; Liu C; Weeks LS
Antimicrob Agents Chemother; 1987 Aug; 31(8):1210-5. PubMed ID: 2820300
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Smith KR; Cobbs CG
Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
[TBL] [Abstract][Full Text] [Related]
8. Activity of ciprofloxacin against methicillin-resistant Staphylococcus aureus.
Smith SM; Eng RH
Antimicrob Agents Chemother; 1985 May; 27(5):688-91. PubMed ID: 3160301
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Ryan BM; Mazzucco CE; Lawrence LE; Ho H; Warr G; Barrett JF; Frosco M
Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):27-34. PubMed ID: 11913498
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of a new tetracyclic quinolone, No. 5290, against norfloxacin- and ciprofloxacin-resistant strains of Staphylococcus aureus.
Kotera Y; Inoue Y; Ohashi M; Ito K; Tsukamoto G
Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2644-6. PubMed ID: 1666861
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin-gentamicin synergism revisited: effect of gentamicin susceptibility of methicillin-resistant Staphylococcus aureus.
Mulazimoglu L; Drenning SD; Muder RR
Antimicrob Agents Chemother; 1996 Jun; 40(6):1534-5. PubMed ID: 8726033
[TBL] [Abstract][Full Text] [Related]
12. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
Watanakunakorn C; Tisone JC
Antimicrob Agents Chemother; 1982 Nov; 22(5):903-5. PubMed ID: 6924825
[TBL] [Abstract][Full Text] [Related]
13. Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model.
Aeschlimann JR; Allen GP; Hershberger E; Rybak MJ
Antimicrob Agents Chemother; 2000 Nov; 44(11):2991-8. PubMed ID: 11036011
[TBL] [Abstract][Full Text] [Related]
14. Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
Bogdanovich T; Esel D; Kelly LM; Bozdogan B; Credito K; Lin G; Smith K; Ednie LM; Hoellman DB; Appelbaum PC
Antimicrob Agents Chemother; 2005 Aug; 49(8):3325-33. PubMed ID: 16048943
[TBL] [Abstract][Full Text] [Related]
15. MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
Visalli MA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Feb; 40(2):362-6. PubMed ID: 8834881
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
Kotlus BS; Wymbs RA; Vellozzi EM; Udell IJ
Am J Ophthalmol; 2006 Nov; 142(5):726-9. PubMed ID: 17056356
[TBL] [Abstract][Full Text] [Related]
17. Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.
Venezio FR; Tatarowicz W; DiVincenzo CA; O'Keefe JP
Antimicrob Agents Chemother; 1986 Dec; 30(6):940-1. PubMed ID: 3101589
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureus.
Kojima T; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jun; 34(6):1123-7. PubMed ID: 2393270
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of the new 4-quinolone compound Ro 23-6240.
Clarke AM; Zemcov SJ
Eur J Clin Microbiol; 1987 Apr; 6(2):161-4. PubMed ID: 3109895
[TBL] [Abstract][Full Text] [Related]
20. In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Grohs P; Kitzis MD; Gutmann L
Antimicrob Agents Chemother; 2003 Jan; 47(1):418-20. PubMed ID: 12499229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
